Bayer Files for Approval of Gadoquatrane MRI Contrast Agent in Japan
CompanyDrug

Bayer Files for Approval of Gadoquatrane MRI Contrast Agent in Japan

MicroPort CardioFlow to Acquire 49% Stake in La Ronda for RMB 171 Million
CompanyDeals

MicroPort CardioFlow to Acquire 49% Stake in La Ronda for RMB 171 Million

MSD Appoints Kyle Tattle as President of China Operations
Company

MSD Appoints Kyle Tattle as President of China Operations

Zelgen's Jaktinib Receives NMPA Approval for Myelofibrosis Treatment
CompanyDrug

Zelgen’s Jaktinib Receives NMPA Approval for Myelofibrosis Treatment

MSD and Daiichi Sankyo Withdraw US Filing for Patritumab Deruxtecan in EGFR-Mutated NSCLC
Others

MSD and Daiichi Sankyo Withdraw US Filing for Patritumab Deruxtecan in EGFR-Mutated NSCLC

Fosun Pharma's FCN-159 and FCN-437c Win NMPA Marketing Approvals
CompanyDrug

Fosun Pharma’s FCN-159 and FCN-437c Win NMPA Marketing Approvals

CSPC Pharmaceutical in Advanced Talks for $5B Licensing Deals
CompanyDeals

CSPC Pharmaceutical in Advanced Talks for $5B Licensing Deals

Acotec Scientific's E-Peridge Balloon Catheter Approved by China's NMPA
CompanyMedical Device

Acotec Scientific’s E-Peridge Balloon Catheter Approved by China’s NMPA

Jiangsu Hengrui Secures NMPA Approvals for Trastuzumab Rezetecan, Famitinib and HR20013
CompanyDrug

Jiangsu Hengrui Secures NMPA Approvals for Trastuzumab Rezetecan, Famitinib and HR20013

NMPA Approves Mabwell's 8MW0511 for Febrile Neutropenia Prevention
CompanyDrug

NMPA Approves Mabwell’s 8MW0511 for Febrile Neutropenia Prevention

Hinova's Deutenzalutamide Approved for Metastatic Prostate Cancer in China
CompanyDrug

Hinova’s Deutenzalutamide Approved for Metastatic Prostate Cancer in China

Sino Biopharmaceutical's TQB2868 Shows Strong Results in Phase II Pancreatic Cancer Trial
CompanyDrug

Sino Biopharmaceutical’s TQB2868 Shows Strong Results in Phase II Pancreatic Cancer Trial